BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33886374)

  • 1. Neurotoxic Effects of Childhood Cancer Therapy and Its Potential Neurocognitive Impact.
    Phillips NS; Duke ES; Schofield HT; Ullrich NJ
    J Clin Oncol; 2021 Jun; 39(16):1752-1765. PubMed ID: 33886374
    [No Abstract]   [Full Text] [Related]  

  • 2. Psychosexual development and satisfaction in long-term survivors of childhood cancer: Neurotoxic treatment intensity as a risk indicator.
    Lehmann V; Tuinman MA; Keim MC; Winning AM; Olshefski RS; Bajwa RPS; Hagedoorn M; Gerhardt CA
    Cancer; 2017 May; 123(10):1869-1876. PubMed ID: 28165611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive Risk in Survivors of Pediatric Brain Tumors.
    Oyefiade A; Paltin I; De Luca CR; Hardy KK; Grosshans DR; Chintagumpala M; Mabbott DJ; Kahalley LS
    J Clin Oncol; 2021 Jun; 39(16):1718-1726. PubMed ID: 33886348
    [No Abstract]   [Full Text] [Related]  

  • 4. Cognitive Impairment in Survivors of Pediatric Extracranial Solid Tumors and Lymphomas.
    Foster R; Zheng DJ; Netson-Amore KL; Kadan-Lottick NS
    J Clin Oncol; 2021 Jun; 39(16):1727-1740. PubMed ID: 33886354
    [No Abstract]   [Full Text] [Related]  

  • 5. Anesthetic neurotoxicity: what to tell the parents?
    Nemergut ME; Aganga D; Flick RP
    Paediatr Anaesth; 2014 Jan; 24(1):120-6. PubMed ID: 24283891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic hepatitis C virus infection and neurocognitive function in adult survivors of childhood cancer.
    Studaway A; Ojha RP; Brinkman TM; Zhang N; Baassiri M; Banerjee P; Ehrhardt MJ; Srivastava D; Robison LL; Hudson MM; Krull KR
    Cancer; 2017 Nov; 123(22):4498-4505. PubMed ID: 28743159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotoxicity of general anesthetics: an update.
    Vlisides P; Xie Z
    Curr Pharm Des; 2012; 18(38):6232-40. PubMed ID: 22762477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing interventions for cancer-related cognitive dysfunction in childhood cancer survivors.
    Castellino SM; Ullrich NJ; Whelen MJ; Lange BJ
    J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 25080574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cassia poisoning behind mysterious disease in children in Uttarakhand.
    Kumar A
    Indian Pediatr; 2008 May; 45(5):423. PubMed ID: 18515938
    [No Abstract]   [Full Text] [Related]  

  • 10. Developmental neurotoxicity test guidelines: problems and perspectives.
    Tohyama C
    J Toxicol Sci; 2016; 41(Spec):SP69-SP79. PubMed ID: 28250285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A better approach to in vivo developmental neurotoxicity assessment: Alignment of rodent testing with effects seen in children after neurotoxic exposures.
    Vorhees CV; Sprowles JN; Regan SL; Williams MT
    Toxicol Appl Pharmacol; 2018 Sep; 354():176-190. PubMed ID: 29544898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental arsenic neurotoxicity in retrospect.
    Grandjean P; Murata K
    Epidemiology; 2007 Jan; 18(1):25-6. PubMed ID: 17179758
    [No Abstract]   [Full Text] [Related]  

  • 13. Carcinogenic and neurotoxic risks of acrylamide consumed through caffeinated beverages among the lebanese population.
    El-Zakhem Naous G; Merhi A; Abboud MI; Mroueh M; Taleb RI
    Chemosphere; 2018 Oct; 208():352-357. PubMed ID: 29885500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment and Monitoring of Neurocognitive Function in Pediatric Cancer.
    Jacola LM; Partanen M; Lemiere J; Hudson MM; Thomas S
    J Clin Oncol; 2021 Jun; 39(16):1696-1704. PubMed ID: 33886364
    [No Abstract]   [Full Text] [Related]  

  • 15. Lack of evidence of encephalopathy related to pertussis vaccine: active surveillance by IMPACT, Canada, 1993-2002.
    Moore DL; Le Saux N; Scheifele D; Halperin SA;
    Pediatr Infect Dis J; 2004 Jun; 23(6):568-71. PubMed ID: 15194842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiologic principles in the evaluation of suspected neurotoxic disorders.
    Garabrant DH
    Neurol Clin; 2000 Aug; 18(3):631-48. PubMed ID: 10873235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotoxicity of European viperids in Italy: Pavia Poison Control Centre case series 2001-2011.
    Lonati D; Giampreti A; Rossetto O; Petrolini VM; Vecchio S; Buscaglia E; Mazzoleni M; Chiara F; Aloise M; Gentilli A; Montecucco C; Coccini T; Locatelli CA
    Clin Toxicol (Phila); 2014 Apr; 52(4):269-76. PubMed ID: 24708390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study on the neurological complications of breast cancer and its treatment: Updated analysis three years after cancer diagnosis.
    Fontes F; Pereira S; Castro-Lopes JM; Lunet N
    Breast; 2016 Oct; 29():31-8. PubMed ID: 27394676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood Neurotoxicity and Brain Resilience to Adverse Events during Adulthood.
    Williams AM; Cheung YT; Hyun G; Liu W; Ness KK; Ehrhardt MJ; Mulrooney DA; Bhakta N; Banerjee P; Brinkman TM; Green DM; Chemaitilly W; Huang IC; Srivastava D; Hudson MM; Robison LL; Krull KR
    Ann Neurol; 2021 Mar; 89(3):534-545. PubMed ID: 33274777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboplatin and vincristine neurotoxicity in the treatment of pediatric low-grade gliomas.
    Rosca L; Robert-Boire V; Delisle JF; Samson Y; Perreault S
    Pediatr Blood Cancer; 2018 Nov; 65(11):e27351. PubMed ID: 30014595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.